Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
142,143,144 In addition to MTL-CEBPA, MiNA Therapeutics has several saRNA candidates in preclinical development for undisclosed tumor types, metabolic diseases, and genetic disorders
N.MurthyS
Mirikizumab for the treatment of moderate to severe ulcerative colitis
Weight loss pens, also known as weight loss injections, are self-administered prescription treatments that look similar to insulin pens
States must cover this indication
Research suggests that resistant starch could also help improve insulin sensitivity
US$ 21.47
US$ 29.57
US$ 29.02
/media/img/mt/2026/07/PeptideGoldRush/original.png){kind=icon}
US$ 25.44
US$ 29.58
US$ 28.21
